Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases - PubMed (original) (raw)
Review
. 2022 Mar;72(3):653-676.
doi: 10.1007/s12031-021-01922-7. Epub 2021 Oct 25.
Affiliations
- PMID: 34697770
- DOI: 10.1007/s12031-021-01922-7
Review
Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases
Akshay Bandiwadekar et al. J Mol Neurosci. 2022 Mar.
Abstract
Neurodegenerative diseases (NDs) such as Alzheimer's disease, Parkinson's disease, Huntington disease, amyotrophic lateral sclerosis, and prion disease affect any part of the brain. The complete mechanism of ND is unknown, but there are some molecular mechanism and chemical process. Natural compounds have better compatibility with the human body along with lesser side effects. Moreover, several studies showed that various natural compounds have significant neuroprotective, potent antioxidant, and anti-inflammatory properties, which are effective for treating the different type of ND. In ND, natural compounds act by various mechanisms such as preventing the generation of reactive oxygen species (ROS), eliminating destructed biomolecules before their accumulation affects cell metabolism, and improving the disease conditions. But due to the presence of the blood-brain barrier (BBB) layer and unfavorable pharmacokinetic properties of natural compounds, their delivery into the brain is limited. To minimize this problem and enhance drug delivery into the brain with an effective therapeutic dose, there is a need to develop a practical novel approach. The various studies showed that nanoformulations and microneedles (MN) containing natural compounds such as quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine A, berberine, baicalein, hesperetin, and retinoic acid effectively improved many ND. In this review, the effect of such natural drug-loaded nanoformulation and MN patches on ND management is discussed, along with their merits and demerits. This review aims to introduce different novel approaches for enhancing natural drug delivery into the brain to manage various neurodegenerative diseases.
Keywords: Microneedles; Nanoparticle; Natural products; Neurodegenerative diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
- Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.
Maiti P, Dunbar GL. Maiti P, et al. Int J Mol Sci. 2018 May 31;19(6):1637. doi: 10.3390/ijms19061637. Int J Mol Sci. 2018. PMID: 29857538 Free PMC article. Review. - Herbal nanoparticles: a targeted approach for neurodegenerative disorder treatment.
Panda P, Mohapatra R. Panda P, et al. J Drug Target. 2024 Dec;32(10):1233-1246. doi: 10.1080/1061186X.2024.2391913. Epub 2024 Aug 14. J Drug Target. 2024. PMID: 39133517 Review. - Microneedles: A Versatile Drug Delivery Carrier for Phytobioactive Compounds as a Therapeutic Modulator for Targeting Mitochondrial Dysfunction in the Management of Neurodegenerative Diseases.
Bandiwadekar A, Khot KB, Gopan G, Jose J. Bandiwadekar A, et al. Curr Neuropharmacol. 2024;22(6):1110-1128. doi: 10.2174/1570159X20666221012142247. Curr Neuropharmacol. 2024. PMID: 36237157 Free PMC article. Review. - Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review.
Moukham H, Lambiase A, Barone GD, Tripodi F, Coccetti P. Moukham H, et al. Nutrients. 2024 Apr 26;16(9):1298. doi: 10.3390/nu16091298. Nutrients. 2024. PMID: 38732545 Free PMC article. Review. - Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
Liu S, Li X. Liu S, et al. Adv Exp Med Biol. 2020;1207:725-730. doi: 10.1007/978-981-15-4272-5_54. Adv Exp Med Biol. 2020. PMID: 32671789 Review.
Cited by
- Development of Microneedle Patch Loaded with Bacopa monnieri Solid Lipid Nanoparticles for the Effective Management of Parkinson's Disease.
Joy D, Jose J, Bibi S, Bandiwadekar A, Gopan G, Mariana Gonçalves Lima C, Bin Emran T, A Alhumaydhi F, Ashtekar H, D S S, Adam Conte-Junior C. Joy D, et al. Bioinorg Chem Appl. 2022 Aug 10;2022:9150205. doi: 10.1155/2022/9150205. eCollection 2022. Bioinorg Chem Appl. 2022. PMID: 35992047 Free PMC article. Retracted. - Alzheimer's Disease: Treatment Strategies and Their Limitations.
Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E. Passeri E, et al. Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954. Int J Mol Sci. 2022. PMID: 36430432 Free PMC article. Review. - Nanophytomedicines as Therapeutic Agents for Parkinson's Disease.
Burns J, Buck AC, D' Souza S, Dube A, Bardien S. Burns J, et al. ACS Omega. 2023 Nov 2;8(45):42045-42061. doi: 10.1021/acsomega.3c04862. eCollection 2023 Nov 14. ACS Omega. 2023. PMID: 38024675 Free PMC article. Review. - Hesperetin, a Citrus Flavonoid, Ameliorates Inflammatory Cytokine-Mediated Inhibition of Oligodendroglial Cell Morphological Differentiation.
Nishino S, Fujiki Y, Sato T, Kato Y, Shirai R, Oizumi H, Yamamoto M, Ohbuchi K, Miyamoto Y, Mizoguchi K, Yamauchi J. Nishino S, et al. Neurol Int. 2022 May 31;14(2):471-487. doi: 10.3390/neurolint14020039. Neurol Int. 2022. PMID: 35736620 Free PMC article. - Investigating the Protective Effects of a Citrus Flavonoid on the Retardation Morphogenesis of the Oligodendroglia-like Cell Line by Rnd2 Knockdown.
Fukatsu S, Miyamoto Y, Oka Y, Ishibashi M, Shirai R, Ishida Y, Endo S, Katoh H, Yamauchi J. Fukatsu S, et al. Neurol Int. 2023 Dec 26;16(1):33-61. doi: 10.3390/neurolint16010003. Neurol Int. 2023. PMID: 38251051 Free PMC article.
References
- Al-Kasasbeh R, Brady AJ, Courtenay AJ et al (2020) Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches. Drug Deliv Transl Res 10:690–705. https://doi.org/10.1007/s13346-020-00727-2 - DOI - PubMed - PMC
- Ameen D, Michniak-Kohn B (2017) Transdermal delivery of dimethyl fumarate for Alzheimer’s disease: Effect of penetration enhancers. Int J Pharm 529:465–473. https://doi.org/10.1016/j.ijpharm.2017.07.031 - DOI - PubMed
- Anand P, Nair HB, Sung B et al (2010) Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Biochem Pharmacol 79:330–338. https://doi.org/10.1016/j.bcp.2009.09.003 - DOI - PubMed
- Arulkumar S, Sabesan M (2012) The behavioral performance tests of Mucuna pruriens gold nanoparticles in the 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine treated mouse model of Parkinsonism. Asian Pac J Trop Dis 2. https://doi.org/10.1016/S2222-1808(12)60210-2
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical